Ultrasound Contrast Agent Warnings Remain Boxed, But Less Monitoring Required
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA rejects a citizen petition requesting removal of the boxed warning in Optison and Definity labeling, but the agency agrees to modified wording to eliminate certain monitoring requirements and include new data, despite misgivings about the quality of the postmarketing studies cited in the petition.